UroGen Pharma Ltd Logo

UroGen Pharma Ltd (URGN): Eigentümerstruktur

Takani Score ?
38.8

Preis (11.09.2026)52W Hoch52W Tief
42,31 US Dollar50,81 US Dollar15,86 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
60 US Dollar51200
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
48.880.56413,046,25

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name UroGen Pharma Ltd
Mitarbeiter 300
Handelsplatz NASDAQ
Ticker Symbol URGN
IPO Datum 2017-05-04
Adresse 400 Alexander Park Drive, Princeton, NJ, United States, 08540

Unternehmensführung

RangNamePosition
1Ms. Elizabeth A. BarrettPresident, CEO & Director
2Mr. Jason Drew Smith J.D.General Counsel, Chief Compliance Officer & Corporate Secretary
3Dr. Mark P. Schoenberg M.D.Chief Medical Officer
4Mr. Christopher Degnan CPAChief Financial Officer
5Mr. Vincent I. PerroneSenior Director of Investor Relations
6Ms. Alison HardgroveSenior Vice President of Human Resources
7Dr. Marina Konorty Ph.D.Executive Vice President of Research & Development and Technical Operations
8Mr. James Ottinger R.ph.Executive Vice President of Regulatory Affairs & Quality
9Mr. Michael J. Louie M.D., M.P.H., M.Sc.Chief Development Officer
10Mr. Timothy SimonSenior Vice President of Business Development & Portfolio Strategy

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1RTW INVESTMENTS, LLC9,30%0,19 Mrd. USD
2BlackRock Inc5,82%0,12 Mrd. USD
3The Toronto-Dominion Bank5,35%0,11 Mrd. USD
4Morgan Stanley - Brokerage Accounts5,24%0,11 Mrd. USD
5Kynam Capital Management, LP4,98%0,10 Mrd. USD
6Jefferies Financial Group Inc4,50%0,09 Mrd. USD
7American Century Companies Inc3,45%0,07 Mrd. USD
8SG Americas Securities, LLC3,39%0,07 Mrd. USD
9Frontier Capital Management CO Inc3,09%0,06 Mrd. USD
10SILVERARC CAPITAL MANAGEMENT, LLC3,07%0,06 Mrd. USD
11Opaleye Management Inc2,95%0,06 Mrd. USD
12MENORA MIVTACHIM HOLDINGS LIMITED2,36%0,05 Mrd. USD
13D. E. Shaw & Co LP2,34%0,05 Mrd. USD
14J. Goldman & Co LP1,92%0,04 Mrd. USD
15MPM Oncology Impact Management LP1,91%0,04 Mrd. USD
16Orbimed Advisors LLC1,79%0,04 Mrd. USD
17State Street Corp1,79%0,04 Mrd. USD
18Soleus Capital Management, L.P.1,70%0,04 Mrd. USD
19Migdal Insurance & Financial Holdings Ltd1,58%0,03 Mrd. USD
20The Goldman Sachs Group Inc1,22%0,03 Mrd. USD